Clinical Cardiology 1010 - Clinical Cardiology Alert - Oct 01, 2006

Target Audience:

This activity is intended for the cardiologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical Cardiology
University of California
San Francisco

Peer Reviewer
Rakesh Mishra, MD, FACC
Assistant Professor of Medicine
Weill Medical College
Cornell University
Assistant Attending Physician
NewYork Presbyterian Hospital

Editorial Board Members
John DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia, Charlottesville

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico, Albuquerque

Subjects:

  • ACE Inhibitors for Patients with Normal Left Ventricular Function
  • Ace Inhibitors for Abdominal Aortic Aneurysms
  • Bleeding with Acute Coronary Syndrome
  • Atrial Fibrillation
  • Embolic Risk Post Ablation
  • Another New Biomarker for Cardiovascular Disease;

Objectives:

  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert's physician editor, Michael H. Crawford, MD, is on the speaker's bureau for Pfizer. The peer reviewer, Rakesh Mishra, MD, reports no consultant, stockholder, speaker's bureau, or other financial relationship with any company related to this field of study. Editorial board member John DiMarco, MD, PhD is a consultant for Novartis, and does research for Medtronic and Guidant. Editorial board member Jonathan Abrams, MD serves on the speaker's bureau for Merck, Pfizer, and Parke-Davis.

Copyright 2006 AHC Media. All rights reserved.